Content
All Posts > Content under Pharma/Biotech
Bristol-Myers Squibb: Strong Quality And Attractive Valuation
Article By:
Andres Cardenal
Read
Tuesday, January 28, 2020 5:50 AM EDT
Bristol-Myers Squibb has an outstanding track record of consistent revenue growth and superior profitability. The stock is very reasonably valued at current levels.
Biotech Sector Watch: After JPMorgan Conference
Article By:
Rod Raynovich
Read
Monday, January 27, 2020 2:09 AM EDT
It was only a modest one week drop of 1% in the S&P-500 but investors seemed to be shocked that the run ebbed. The reason for the loss of momentum is not yet clear but ostensibly it was concerns about the coronavirus.
The Man Who Predicted Stocks In 2019 Says This Is What'll Happen In 2020
Article By:
Financial Sense
Read
Sunday, January 26, 2020 3:07 AM EDT
Jim Paulsen, Chief Investment Strategist at the Leuthold Group, who gave us an update on his outlook for 2020. Here's what he told listeners in a recent interview with FS Insider.
Week In Review: South Korea's Celltrion Plans $513 Million Biologics Facility In Wuhan
Article By:
ChinaBio® Today
Read
Saturday, January 25, 2020 4:50 PM EDT
Celltrion, a South Korea biopharma, plans to build a $513 million China biologics manufacturing facility in Wuhan. The company said the plant's 120,000 liter capacity will make it the largest facility in China.
3 Biotech Stocks Likely To Gain As Coronavirus Spreads
Article By:
Zacks Investment Research
Read
Thursday, January 23, 2020 12:59 PM EDT
The following biotech companies would benefit from the 2019-nCoV if an outbreak occurs as feared. These companies are into developing vaccines, which can help authorities to restrict infection caused by the virus.
ACADIA: From Depression To Schizophrenia
Article By:
MoneyShow.com
Read
Wednesday, January 22, 2020 12:19 PM EDT
At the recent JPMorgan conference, ACADIA Pharmaceuticals presented a business update highlighting several catalysts anticipated in 2020.
In this article: ACAD
Revance, Amphastar Named Top 2020 Specialty Pharmaceuticals Ideas At Wells Fargo
Cannabis Central: A 1-Week Reversal Does Not A Trend Reversal Make
Article By:
Lorimer Wilson
Read
Wednesday, January 22, 2020 4:26 AM EDT
A 1-week reversal - even a month of positive returns - does not a trend reversal make. Here are a few companies that have shown performance improvement over the past 3 months and seem to have turned the corner.
Biotechnology Stocks About To Take Off
Article By:
Taki Tsaklanos
Read
Monday, January 20, 2020 10:01 AM EDT
The biotechnology sector is working hard, very hard. It is attempting to take off. It has to overcome 4.5-year horizontal resistance.
In this article: IBB
Top Precision Medicine Stocks
Article By:
Fred Fuld III
Read
Sunday, January 19, 2020 1:13 PM EDT
In precision medicine, the focus is on identifying which approaches will be effective for which patients based on genetic, environmental, and lifestyle factors. For investors, there are a few stocks that participate in this industry.
Week In Review: China's I-Mab Stages $104 Million Nasdaq IPO
Article By:
ChinaBio® Today
Read
Saturday, January 18, 2020 2:34 PM EDT
I-Mab, a Shanghai biotech, raised $104 million in its IPO on the Nasdaq exchange to support its portfolio of biologic products.The offering was priced at $14 per ADS but the price has moved 10% lower to $12.58 in initial trading.